CHELSEY HENRY: Open Payments
NPI 1093152688 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 42 payments from 13 companies in 2025. Trend: 2023 $1,242 · 2024 $1,015 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $125 |
| Novo Nordisk Inc | 5 | $99 |
| Axsome Therapeutics, Inc. | 6 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: Kerendia, CAPLYTA, QULIPTA, Sunosi, VRAYLAR, Ozempic, Wegovy, Auvelity.
Industry payments across TN — which companies pay providers there.
